IBDEI0N3 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10279,1,3,0)
 ;;=3^Vitreous Hemorrhage,Bilateral
 ;;^UTILITY(U,$J,358.3,10279,1,4,0)
 ;;=4^H43.13
 ;;^UTILITY(U,$J,358.3,10279,2)
 ;;=^5005940
 ;;^UTILITY(U,$J,358.3,10280,0)
 ;;=H43.821^^74^674^10
 ;;^UTILITY(U,$J,358.3,10280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10280,1,3,0)
 ;;=3^Vitreomacular Adhesion,Right Eye
 ;;^UTILITY(U,$J,358.3,10280,1,4,0)
 ;;=4^H43.821
 ;;^UTILITY(U,$J,358.3,10280,2)
 ;;=^5005957
 ;;^UTILITY(U,$J,358.3,10281,0)
 ;;=H43.822^^74^674^11
 ;;^UTILITY(U,$J,358.3,10281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10281,1,3,0)
 ;;=3^Vitreomacular Adhesion,Left Eye
 ;;^UTILITY(U,$J,358.3,10281,1,4,0)
 ;;=4^H43.822
 ;;^UTILITY(U,$J,358.3,10281,2)
 ;;=^5005958
 ;;^UTILITY(U,$J,358.3,10282,0)
 ;;=H43.823^^74^674^12
 ;;^UTILITY(U,$J,358.3,10282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10282,1,3,0)
 ;;=3^Vitreomacular Adhesion,Bilateral
 ;;^UTILITY(U,$J,358.3,10282,1,4,0)
 ;;=4^H43.823
 ;;^UTILITY(U,$J,358.3,10282,2)
 ;;=^5005959
 ;;^UTILITY(U,$J,358.3,10283,0)
 ;;=H43.391^^74^674^15
 ;;^UTILITY(U,$J,358.3,10283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10283,1,3,0)
 ;;=3^Vitreous Opacities,Right Eye NEC
 ;;^UTILITY(U,$J,358.3,10283,1,4,0)
 ;;=4^H43.391
 ;;^UTILITY(U,$J,358.3,10283,2)
 ;;=^5005949
 ;;^UTILITY(U,$J,358.3,10284,0)
 ;;=H43.392^^74^674^16
 ;;^UTILITY(U,$J,358.3,10284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10284,1,3,0)
 ;;=3^Vitreous Opacities,Left Eye NEC
 ;;^UTILITY(U,$J,358.3,10284,1,4,0)
 ;;=4^H43.392
 ;;^UTILITY(U,$J,358.3,10284,2)
 ;;=^5005950
 ;;^UTILITY(U,$J,358.3,10285,0)
 ;;=S05.31XA^^74^675^1
 ;;^UTILITY(U,$J,358.3,10285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10285,1,3,0)
 ;;=3^Ocular Laceration w/o Loss of Intraoc Tissue,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,10285,1,4,0)
 ;;=4^S05.31XA
 ;;^UTILITY(U,$J,358.3,10285,2)
 ;;=^5020606
 ;;^UTILITY(U,$J,358.3,10286,0)
 ;;=S05.32XA^^74^675^2
 ;;^UTILITY(U,$J,358.3,10286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10286,1,3,0)
 ;;=3^Ocular Laceration w/o Loss of Intraoc Tissue,Left Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,10286,1,4,0)
 ;;=4^S05.32XA
 ;;^UTILITY(U,$J,358.3,10286,2)
 ;;=^5020609
 ;;^UTILITY(U,$J,358.3,10287,0)
 ;;=S01.121A^^74^675^3
 ;;^UTILITY(U,$J,358.3,10287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10287,1,3,0)
 ;;=3^Laceration w/ FB,Right Eyelid,Init Encntr
 ;;^UTILITY(U,$J,358.3,10287,1,4,0)
 ;;=4^S01.121A
 ;;^UTILITY(U,$J,358.3,10287,2)
 ;;=^5020066
 ;;^UTILITY(U,$J,358.3,10288,0)
 ;;=S01.122A^^74^675^4
 ;;^UTILITY(U,$J,358.3,10288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10288,1,3,0)
 ;;=3^Laceration w/ FB,Left Eyelid,Init Encntr
 ;;^UTILITY(U,$J,358.3,10288,1,4,0)
 ;;=4^S01.122A
 ;;^UTILITY(U,$J,358.3,10288,2)
 ;;=^5134190
 ;;^UTILITY(U,$J,358.3,10289,0)
 ;;=S01.111A^^74^675^5
 ;;^UTILITY(U,$J,358.3,10289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10289,1,3,0)
 ;;=3^Laceration w/o FB,Right Eyelid,Init Encntr
 ;;^UTILITY(U,$J,358.3,10289,1,4,0)
 ;;=4^S01.111A
 ;;^UTILITY(U,$J,358.3,10289,2)
 ;;=^5020057
 ;;^UTILITY(U,$J,358.3,10290,0)
 ;;=S01.112A^^74^675^6
 ;;^UTILITY(U,$J,358.3,10290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10290,1,3,0)
 ;;=3^Laceration w/o FB,Left Eyelid,Init Encntr
 ;;^UTILITY(U,$J,358.3,10290,1,4,0)
 ;;=4^S01.112A
 ;;^UTILITY(U,$J,358.3,10290,2)
 ;;=^5020060
